Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel M Green

Showing results (71-80 of 198) with videos related to

Pageof 20
Sort By:
Cancer|March 3, 2015
Validity of anthropometric measurements for characterizing obesity among adult survivors of childhood cancer: A report from the St. Jude Lifetime Cohort StudyRobyn E Karlage, Carmen L Wilson, Nan Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2009
High-risk populations identified in Childhood Cancer Survivor Study investigations: implications for risk-based surveillanceMelissa M Hudson, Daniel A Mulrooney, Daniel C Bowers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2005
Rhabdoid tumor of the kidney in the National Wilms' Tumor Study: age at diagnosis as a prognostic factorGail E Tomlinson, Norman E Breslow, Jeffrey Dome, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 6, 2013
Clinicopathologic findings predictive of relapse in children with stage III favorable-histology Wilms tumorPeter F Ehrlich, James R Anderson, Michael L Ritchey, et al.
American Journal of Obstetrics and Gynecology|July 29, 2014
Lifestyle, distress, and pregnancy outcomes in the Childhood Cancer Survivor Study cohortPrasad L Gawade, Kevin C Oeffinger, Charles A Sklar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2009
Predicting relapse in favorable histology Wilms tumor using gene expression analysis: a report from the Renal Tumor Committee of the Children's Oncology GroupChiang-Ching Huang, Samantha Gadd, Norman Breslow, et al.
Annals of Surgery|September 5, 2009
Hepatic metastasis at diagnosis in patients with Wilms tumor is not an independent adverse prognostic factor for stage IV Wilms tumor: a report from the Children's Oncology Group/National Wilms Tumor Study GroupPeter F Ehrlich, Fernando A Ferrer, Michael L Ritchey, et al.
Blood Advances|January 4, 2018
Chronic disease burden and frailty in survivors of childhood HSCT: a report from the St. Jude Lifetime Cohort StudyHesham M Eissa, Lu Lu, Malek Baassiri, et al.
BMJ (Clinical Research Ed.)|December 10, 2009
Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohortDaniel A Mulrooney, Mark W Yeazel, Toana Kawashima, et al.
Cancer|August 27, 2004
Doxorubicin for favorable histology, Stage II-III Wilms tumor: results from the National Wilms Tumor StudiesNorman E Breslow, San-San Ou, J Bruce Beckwith, et al.
Pageof 20

Showing results (71-80 of 198) with videos related to

Sort By:
Pageof 20
Cancer|March 3, 2015
Validity of anthropometric measurements for characterizing obesity among adult survivors of childhood cancer: A report from the St. Jude Lifetime Cohort StudyRobyn E Karlage, Carmen L Wilson, Nan Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2009
High-risk populations identified in Childhood Cancer Survivor Study investigations: implications for risk-based surveillanceMelissa M Hudson, Daniel A Mulrooney, Daniel C Bowers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2005
Rhabdoid tumor of the kidney in the National Wilms' Tumor Study: age at diagnosis as a prognostic factorGail E Tomlinson, Norman E Breslow, Jeffrey Dome, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 6, 2013
Clinicopathologic findings predictive of relapse in children with stage III favorable-histology Wilms tumorPeter F Ehrlich, James R Anderson, Michael L Ritchey, et al.
American Journal of Obstetrics and Gynecology|July 29, 2014
Lifestyle, distress, and pregnancy outcomes in the Childhood Cancer Survivor Study cohortPrasad L Gawade, Kevin C Oeffinger, Charles A Sklar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2009
Predicting relapse in favorable histology Wilms tumor using gene expression analysis: a report from the Renal Tumor Committee of the Children's Oncology GroupChiang-Ching Huang, Samantha Gadd, Norman Breslow, et al.
Annals of Surgery|September 5, 2009
Hepatic metastasis at diagnosis in patients with Wilms tumor is not an independent adverse prognostic factor for stage IV Wilms tumor: a report from the Children's Oncology Group/National Wilms Tumor Study GroupPeter F Ehrlich, Fernando A Ferrer, Michael L Ritchey, et al.
Blood Advances|January 4, 2018
Chronic disease burden and frailty in survivors of childhood HSCT: a report from the St. Jude Lifetime Cohort StudyHesham M Eissa, Lu Lu, Malek Baassiri, et al.
BMJ (Clinical Research Ed.)|December 10, 2009
Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohortDaniel A Mulrooney, Mark W Yeazel, Toana Kawashima, et al.
Cancer|August 27, 2004
Doxorubicin for favorable histology, Stage II-III Wilms tumor: results from the National Wilms Tumor StudiesNorman E Breslow, San-San Ou, J Bruce Beckwith, et al.
Pageof 20